Autopsy report · NCT05511519
Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis
Cause of deathFunding or business
“Sponsor decision”
Life of this trial
- Ran for about 1 year 6 months before it stopped.
- 47 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Aclaris Therapeutics, Inc.
- Sponsor type
- Industry
- Conditions
- Psoriatic Arthritis
- Interventions
- ATI-450; Placebo Oral Tablet
- Participants
- 47
- Sites
- 22
- Countries
- Poland, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.